Sign inJoin waitlistJoin the waitlist

Sasha Stanton

, Assistant Member · Providence Health & Services - Oregon

Credentials: · · · · · ·

History

Providence Health & Services - Oregon
Present

Medical oncologist
2020–2023
Earle A. Chiles Research Institute
From 2020
University of Washington Department Hematology Oncology
2014–2017
New York-Presbyterian University Hospital of Columbia and Cornell
2011–2014
American Medical Association
2008–2011
Albert Einstein College of Medicine
2004–2008

Research

Clinical significance of tumor-infiltrating lymphocytes in breast cancer
Review · Journal for ImmunoTherapy of Cancer · 2016 · First of 2 authors · Corresponding · 654 citations
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review
Systematic review or meta-analysis · JAMA Oncology · 2016 · First of 3 authors · 504 citations
Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays
Nature Biotechnology · 2000 · 228 citations

MD
Mary Disis
19 papers
John Liao
3 papers
BJ
Bruce Johnson
2 papers
Edmond Marzbani
2 papers · 1 as a fellow
Laura Kennedy
2 papers
LS
Lupe Salazar
2 papers
Matthew Meyerson
2 papers
Suzanne Dintzis
2 papers
Vk Gadi
2 papers
William Gwin
2 papers
Alan Su
1 paper · 1 as a fellow
Alison Conlin
1 paper

Clinical trials

CAN1012 in Pre-Malignant DCIS and LCIS
Principal investigator · Not yet recruiting · Phase 1
Providence Health & Services
2026–2035
Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer
Principal investigator · Active not recruiting · Phase 1
Providence Health & Services
2021–2026
Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients
Sub-investigator · Recruiting · Phase 2
Providence Health & Services
2024–2029